IQVIA HOLDINGS INC. Deferred Income Tax Liabilities, Net
IQVIA HOLDINGS INC. (IQV) had Deferred Income Tax Liabilities, Net of $159.00 million as of 2026-03-31, per its 10-Q filed 2026-05-05.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredIncomeTaxLiabilitiesNet · last filed 2026-05-05
- 2026-03-31: Deferred Income Tax Liabilities, Net $159.00M.
- 2025-12-31: Deferred Income Tax Liabilities, Net $179.00M.
- 2025-09-30: Deferred Income Tax Liabilities, Net $207.00M.
- 2025-06-30: Deferred Income Tax Liabilities, Net $216.00M.
| Period end | Deferred Income Tax Liabilities, Net | Deferred Income Tax Liabilities, Net as first filed |
|---|---|---|
| 2026-03-31 | $159.00M 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $179.00M 10-Q · filed 2026-05-05 | |
| 2025-09-30 | $207.00M 10-Q · filed 2025-10-28 | |
| 2025-06-30 | $216.00M 10-Q · filed 2025-07-22 | |
| 2025-03-31 | $197.00M 10-Q · filed 2025-05-06 | |
| 2024-12-31 | $196.00M 10-K · filed 2026-02-17 | |
| 2024-09-30 | $128.00M 10-Q · filed 2024-10-31 | |
| 2024-06-30 | $149.00M 10-Q · filed 2024-07-22 | |
| 2024-03-31 | $164.00M 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $202.00M 10-K · filed 2025-02-13 | |
| 2023-09-30 | $365.00M 10-Q · filed 2023-11-01 | |
| 2023-06-30 | $367.00M 10-Q · filed 2023-08-01 | |
| 2023-03-31 | $421.00M 10-Q · filed 2023-04-28 | |
| 2022-12-31 | $464.00M 10-K · filed 2024-02-15 | |
| 2022-09-30 | $560.00M 10-Q · filed 2022-10-27 | |
| 2022-06-30 | $494.00M 10-Q · filed 2022-07-22 | |
| 2022-03-31 | $455.00M 10-Q · filed 2022-04-28 | |
| 2021-12-31 | $410.00M 10-K · filed 2023-02-15 | |
| 2021-09-30 | $297.00M 10-Q · filed 2021-10-22 | |
| 2021-06-30 | $266.00M 10-Q · filed 2021-07-28 | |
| 2021-03-31 | $337.00M 10-Q · filed 2021-04-23 | |
| 2020-12-31 | $338.00M 10-K · filed 2022-02-16 | |
| 2020-09-30 | $429.00M 10-Q · filed 2020-10-22 | |
| 2020-06-30 | $539.00M 10-Q · filed 2020-07-23 | |
| 2020-03-31 | $618.00M 10-Q · filed 2020-04-30 | |
| 2019-12-31 | $646.00M 10-K · filed 2021-02-12 | $527.00M 10-K · filed 2020-02-18 |
| 2018-12-31 | $627.00M 10-K · filed 2020-02-18 | |
| 2017-12-31 | $786.00M 10-K · filed 2019-02-19 | $820.00M 10-K · filed 2018-02-16 |
| 2016-12-31 | $2.04B 10-K · filed 2018-02-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |